Lung Cancer statistics and solutions

Lung Cancer is the Deadliest Cancer


Estimated new cases of lung cancer diagnosed in 2019 (American Cancer Society)


Estimated deaths caused by lung cancer in 2019 (American Cancer Society)

Lung cancer accounts for 25% of all cancer deaths and causes more deaths  than the next three cancers combined. Go2Foundation

Survival Rates Are Very Low

The overall five-year relative survival rate for lung cancer is low as a result of the large proportion of cases diagnosed with advance stage disease (American Cancer Society). Lung Cancer kills almost twice as many women as breast cancer and has since 1987 (LCFA America).



The 5-year survival rate for lung cancer drops dramatically as stages progress (Go2Foundation). 

Early Diagnosis 57.7% survival

21.5% of diagnosis in this stage (localized – confined to primary site)

*American Lung Association State of Lung Cancer 2019

Distant Diagnosis

48.5% of diagnosis in this stage (cancer has metastisized)

*American Lung Association State of Lung Cancer 2019

Survival rates for lung cancer pale in comparison to other cancers

Lung Cancer - Ave 5-Yr Survival Rate
Lung Cancer 21.7%
Breast Cancer - Ave 5-Yr Survival Rate
Breast Cancer 90%
Prostate Cancer - Ave 5-Yr Survival Rate
Prostate Cancer 99%
Colorectal Cancer - Ave 5-Yr Survival Rate
Colorectal Cancer 65%

Yet, Lung Cancer Screening Rates Are Some of the Lowest!

In 2015, of the estimated 6.8 million eligible current and former smokers, only 262,700 received screening. (American Lung Association State of Lung Cancer)

Lung Cancer Screening Rate - 2015
Lung Cancer 4.2%
Breast Cancer Screening Rate - 2015
Breast Cancer 50%
Prostate Cancer Screening Rate
Prostate Cancer 35%
Colorectal Cancer Screening Rate
Colorectal Cancer 63%

If everyone currently eligible were screened, close to 48,000 lives could be saved.

*American Lung Association State of Lung Cancer 2019

We do this by partnering with healthcare organizations to improve lung cancer screening programs, decrease administrative workload, increase hospital revenue, and create healthier communities.

Thynk Health’s Lung Cancer Module integrates with your existing hospital systems (EHR, DICOM, PACS, scheduling, and more) to extract critical data from patient health records. Analyzing patient demographics and medical history, the Thynk Health lung cancer module flags patients at a higher risk of lung cancer and reports findings to providers. Those eligible for lung cancer screenings can be automatically notified via custom mailings and communications. LEARN MORE

With just one-click, automatically populate all ACR Registry submission fields and deliver to the ACR without disrupting physician workflow. Thynk Health’s lung cancer screening solution works with any EHR, to remove unnecessary manual data entry and automate workflows and patient communications. LEARN MORE

Provide education, screening results, appointment and screening eligibility reminders designed to improve patient care and retention without expanding your workload. LEARN MORE

Increase the effectiveness of your lung cancer screening program with automated tracking of incidental findings, missed appointments, overdue annual screenings and overdue follow-up, diagnostic procedures. Prevent patients from falling through the cracks of complex healthcare systems, by ensuring they are flagged and followed-up with at critical points in their health journey. LEARN MORE

Engage providers in your screening program by sharing important information like number of their patients eligible for lung cancer screenings and number of lung cancer screenings ordered. LEARN MORE

Our simple dashboard captures quality and operational data, giving hospitals access to data and analytics to improve outcomes and efficiency. LEARN MORE

Scroll to Top